Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
69%
Total
Publications
519
Total Open
Publications
360
Total
Citations
69K
Open Access
Percentage
69%
Total
Publications
519
Total Open
Publications
360
Total
Citations
69K
Breakdown
Publisher Open
16%
Both
33%
Other Platform Open
19%
Closed
32%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
130
Hybrid 17%
43
No Guarantees 31%
76
Other Platform Open
Domain 53%
144
Other Internet 38%
103
Institution 13%
34
Preprint 10%
26
Public 5%
14
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 144 |
DOI | Other Internet | 103 |
bioRxiv | Preprint | 24 |
Figshare | Public | 14 |
Harvard University | Institution | 11 |
Europe PMC | Domain | 8 |
Massachusetts Institute of Technology | Institution | 4 |
University of Turin | Institution | 3 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |